Steven Lacy
Impact in
Papers in
- Oncology 14
- Pancreatic and Hepatic Oncology Research 9
- Polyomavirus and related diseases 3
-
- Renal cell carcinoma treatment 7
- Co-authors
- Linh T. Nguyen (11 shared papers)Dale Miles (9 shared papers)Michael J. M. Hitchcock (2 shared papers)Jaymes Holland (3 shared papers)Dirk B. Mendel (2 shared papers)Linh Thuy Nguyen (2 shared papers)Kenneth C. Cundy (1 shared paper)Pierre Tellier (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)The Journal of Clinical Pharmacology (4 papers)Cancer Chemotherapy and Pharmacology (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)Anti-Cancer Drugs (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Steven Lacy
29 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 99
- Oncology 419
- Virology 72
- Hepatology 112
- Epidemiology 346
- Pharmacology 86
Countries citing papers authored by Steven Lacy
This map shows the geographic impact of Steven Lacy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Lacy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Lacy more than expected).
Fields of papers citing papers by Steven Lacy
This network shows the impact of papers produced by Steven Lacy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Lacy. The network helps show where Steven Lacy may publish in the future.
Co-authors
The 25 scholars most cited alongside Steven Lacy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 218 | |
| 2 | 2016 | 100 | |
| 3 | 1998 | 81 | |
| 4 | 1998 | 78 | |
| 5 | 1994 | 70 | |
| 6 | 2015 | 66 | |
| 7 | 2015 | 66 | |
| 8 | 2015 | 63 | |
| 9 | 2016 | 46 | |
| 10 | 2016 | 45 | |
| 11 | 2018 | 41 | |
| 12 | 2011 | 40 | |
| 13 | 2002 | 32 | |
| 14 | 2015 | 30 | |
| 15 | 2018 | 28 | |
| 16 | 1996 | 22 | |
| 17 | 2019 | 22 | |
| 18 | 1995 | 21 | |
| 19 | 1989 | 21 | |
| 20 | 2019 | 18 |
About Steven Lacy
Steven Lacy is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Hematology and Cancer Research, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (9 papers), Chronic Myeloid Leukemia Treatments (8 papers), Renal cell carcinoma treatment (7 papers), Cancer Genomics and Diagnostics (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), Virus-based gene therapy research (3 papers), Statistical Methods in Clinical Trials (3 papers) and Polyomavirus and related diseases (3 papers). The work is most often cited by research in Oncology (419 citations), Virology (72 citations), Hepatology (112 citations), Epidemiology (346 citations) and Pharmacology (86 citations). Steven Lacy has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Linh T. Nguyen, Dale Miles, Michael J. M. Hitchcock, Jaymes Holland, Dirk B. Mendel, Linh Thuy Nguyen, Kenneth C. Cundy, Pierre Tellier, William A. Lee and K. J. Jakeman. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Clinical Pharmacology, Cancer Chemotherapy and Pharmacology, Antimicrobial Agents and Chemotherapy and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.